van den Berg Inge, Coebergh van den Braak Robert R J, van Vugt Jeroen L A, Ijzermans Jan N M, Buettner Stefan
Department of Surgery, Erasmus MC - University Medical Center Rotterdam, Rotterdam, 3015 GD, The Netherlands.
World J Surg Oncol. 2021 Apr 5;19(1):96. doi: 10.1186/s12957-021-02207-4.
Colorectal cancer is the third most common type of cancer in the world. We characterize a cohort of patients who survived up to 5 years without recurrence and identify factors predicting the probability of cure.
We analyzed data of patients who underwent curative intent surgery for stage I-III CRC between 2007 and 2012 and who had had been included in a large multicenter study in the Netherlands. Cure was defined as 5-year survival without recurrence. Survival data were retrieved from a national registry.
Analysis of data of 754 patients revealed a cure rate of 65% (n = 490). Patients with stage I disease and T1- and N0-tumor had the highest probability of cure (94%, 95% and 90%, respectively). Those with a T4-tumor or N2-tumor had the lowest probability of cure (62% and 50%, respectively). A peak in the mortality rate for older patients early in follow-up suggests early excess mortality as an explanation. A similar trend was observed for stage III disease, poor tumor grade, postoperative complications, sarcopenia, and R1 resections. Patients with stage III disease, poor tumor grade, postoperative complications, sarcopenia, and R1 resections show a similar trend for decrease in CSS deaths over time.
In the studied cohort, the probability of cure for patients with stage I-III CRC ranged from 50 to 95%. Even though most patients will be cured from CRC with standard therapy, standard therapy is insufficient for those with poor prognostic factors, such as high T- and N-stage and poor differentiation grade.
结直肠癌是全球第三大常见癌症类型。我们对一组存活达5年且无复发的患者进行了特征分析,并确定了预测治愈可能性的因素。
我们分析了2007年至2012年间接受I - III期结直肠癌根治性手术且纳入荷兰一项大型多中心研究的患者数据。治愈定义为5年无复发存活。生存数据从国家登记处获取。
对754例患者的数据进行分析显示,治愈率为65%(n = 490)。I期疾病以及T1和N0期肿瘤的患者治愈概率最高(分别为94%、95%和90%)。T4期肿瘤或N2期肿瘤的患者治愈概率最低(分别为62%和50%)。随访早期老年患者死亡率出现峰值,提示早期额外死亡率可作为一种解释。III期疾病、肿瘤分级差、术后并发症、肌肉减少症和R1切除也观察到类似趋势。III期疾病、肿瘤分级差、术后并发症、肌肉减少症和R1切除的患者随着时间推移CSS死亡减少呈现类似趋势。
在本研究队列中,I - III期结直肠癌患者的治愈概率为50%至95%。尽管大多数患者通过标准治疗可治愈结直肠癌,但对于具有高T和N分期以及低分化分级等不良预后因素的患者,标准治疗并不充分。